Atlantic Health Partners

What Atlantic Health Partners does

Atlantic Health Partners, Inc. is a privately-held U.S. healthcare services company founded in 2007 and headquartered in Boca Raton, Florida. It operates as the nation's leading vaccine buying group, aggregating purchasing power across more than 45,000 clinicians in all 50 states to negotiate favorable vaccine pricing, payment terms, and procurement conditions directly with major manufacturers including Merck, Sanofi, GSK, Pfizer, Seqirus, AstraZeneca, Moderna, and Bavarian Nordic. The company is structured as Atlantic Health Partners, Inc., with apparent legal affiliation to MHA Inc. via shared terms/privacy policy and web infrastructure.

The core product is a membership-based vaccine purchasing program covering pediatric, adolescent, adult, influenza, and travel vaccines. Members—physicians, physician organizations, health systems, and medical practices—enroll directly through the company website and gain access to negotiated manufacturer pricing, purchasing support, program management assistance, reimbursement guidance, advocacy, and educational content such as the Immunization Insights blog and clinical webinars. New vaccine products are added periodically (e.g., Pfizer's Prevnar 13 added in January 2021).

Revenue is generated through the buying group economics typical of Group Purchasing Organizations (GPOs): the company monetizes via membership-based commercial relationships with member providers and manufacturer-side arrangements, though specific fee structures, spreads, or administrative fees are not publicly disclosed. The GTM motion is sales-led, with direct membership recruitment supported by content marketing (blog, resource center), email newsletters, and seasonal webinars co-hosted with respiratory illness vaccine manufacturers. The company has 11-50 employees, indicating a relatively lean operation relative to its 45,000+ clinician member base.

Name

Atlantic Health Partners

Legal name

Atlantic Health Partners, Inc.

Website

https://atlantichealthpartners.com

Company type

Private

Founded year

2007

Operating status

Operating

Headcount range

11–50 employees

Short description

Atlantic Health Partners is a privately-held U.S. vaccine buying group founded in 2007 that aggregates purchasing power across 45,000+ clinicians in all 50 states, negotiating favorable pricing and terms with major vaccine manufacturers for physicians, health systems, and medical practices.

Ownership category

akta.pro rank

Product category

Healthcare Group Purchasing

NAICS

Blood and Organ Banks (621991)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Vaccine Procurement, Tendering & Immunization Supply Programs (HLAIAEAN)

akta.pro secondary industries

Vaccines & Cold-Chain Pharmaceutical Distributors (HLAIAJAG), Vaccine Ordering, Inventory Management & Cold-Chain Logistics (HLAJAHAF), Public & Private Vaccine Provider Networks (Clinics/Pharmacies/Physicians) (HLAJAHAB), Vaccines & Public Health Product Distribution (CRAOAHAI)

Keywords

• Vaccine purchasing group
• Physician buying group
• Vaccine procurement services
• Group purchasing organization
• Immunization program management

Headquarters

HQ city

Boca Raton

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales

Revenue model

1. Membership-based Vaccine Purchasing Group: Atlantic Health Partners generates revenue by aggregating purchasing power among healthcare providers (physicians, health systems, physician organizations, medical practices). Members gain access to favorable pricing, payment, and purchasing terms for vaccines by working through the buying group. The company works directly with leading vaccine manufacturers including Merck, Sanofi, GSK, Pfizer, Seqirus, AstraZeneca, Moderna, and Bavarian Nordic.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

Atlantic Health Partners operates the nation's leading vaccine buying group, aggregating purchasing power across healthcare providers to negotiate favorable vaccine pricing, payment, and purchasing terms directly with major vaccine manufacturers. Members—including physicians, health systems, physician organizations, and medical practices—gain access to cost-efficient pricing on pediatric, adolescent, adult, flu, and travel vaccines, along with purchasing support, reimbursement guidance, advocacy, and program management assistance.

Product overview

Atlantic Health Partners operates as a single unified vaccine buying group program, not a modular platform. The core offering is their vaccine purchasing program that provides cost-efficient pricing, purchasing support, and program management to over 45,000 clinicians nationwide. They work directly with all major vaccine manufacturers (Merck, Sanofi, GSK, Pfizer, Seqirus, AstraZeneca, Moderna, Bavarian Nordic) to offer favorable terms across the full vaccine spectrum including pediatric, adolescent, adult, flu, and travel vaccines. Additional offerings include reimbursement guidance, advocacy, new product updates, and education services. Prevnar 13 was added as a specific vaccine product offering in January 2021.

Differentiator

Problem solved

Functional benefit

Products and services

• Atlantic Health Partners Vaccine Buying Group Program A membership-based vaccine buying group program that aggregates purchasing power across physicians, health systems, physician organizations, and medical practices to negotiate favorable pricing, payment, and purchasing terms directly with major vaccine manufacturers. Members gain access to cost-efficient vaccine prices for pediatric, adolescent, adult, flu, and travel vaccines, plus purchasing support, reimbursement guidance, advocacy, and program management assistance.
• Prevnar 13 Vaccine Offering Pfizer's pneumococcal 13-valent conjugate vaccine (Prevnar 13) added to the Atlantic Health Partners buying group program, giving members access to protection against 13 strains of Streptococcus pneumoniae.

Quantifiable outcome

• Serves 45,000+ clinicians nationwide
• +1 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Eight partnerships are on record, tiered core.

• MerckcoreStrategic or Co-development PartnerAtlantic Health Partners works directly with Merck as one of their key vaccine manufacturing partners, offering members access to Merck's vaccine portfolio including pediatric, adolescent, adult, and travel vaccines at favorable pricing terms.
• SanoficoreStrategic or Co-development PartnerSanofi is a key manufacturing partner providing vaccines through Atlantic Health Partners' buying group program, enabling members to access Sanofi's vaccine offerings at negotiated pricing.
• GSKcoreStrategic or Co-development PartnerAtlantic Health Partners partners with GSK as a vaccine manufacturer to provide members access to GSK's vaccine portfolio including shingles, flu, and other vaccines at favorable pricing.
• PfizercoreStrategic or Co-development PartnerPfizer is a key vaccine manufacturing partner, with Atlantic Health Partners announcing addition of Prevnar 13 to their program effective January 1, 2021, giving members access to Pfizer's pneumococcal vaccine.
• SeqiruscoreStrategic or Co-development PartnerSeqirus is a key influenza and pandemic vaccine manufacturer partner, with Atlantic Health Partners offering members access to Seqirus flu vaccines and pandemic preparedness products.
• AstraZenecacoreStrategic or Co-development PartnerAstraZeneca is a vaccine manufacturing partner providing respiratory illness and other vaccines through Atlantic Health Partners' buying group at favorable terms for members.
• ModernacoreStrategic or Co-development PartnerModerna is a key vaccine manufacturing partner offering mRNA and other vaccines through Atlantic Health Partners' purchasing program.
• Bavarian NordiccoreStrategic or Co-development PartnerBavarian Nordic is a vaccine manufacturing partner providing specialty vaccines through Atlantic Health Partners' buying group at negotiated pricing for members.

Scale indicators4 records

Expansion highlights4 records

Market position

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/AHPVaccines
• Facebookfacebook.com/atlantic-health-partners-101588673225464
• LinkedInlinkedin.com/company/atlantic-health-partners-llc

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Atlantic Health Partners